TARCEVA

Identification of Tarceva

No description

Google image searchProduct monograph

Active ingredient

erlotinib (erlotinib hydrochloride), 150 MG

DIN: 02269023

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: HOFFMANN-LA ROCHE LIMITED

Date: 19-JUL-2005

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EB — Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (ATC, ATC/DDD)
• L01EB02 — ERLOTINIB (ATC/DDD)

Reference brand drug: Tarceva

External Links for Tarceva

Search on Google

• Tarceva side effects
• Tarceva dosage
• erlotinib side effects
• erlotinib dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find tarceva photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.